Skip to main content
FDA issues final guidance on de novo approvals

The FDA has issued final guidance clarifying its requirements for applications for de novo approval. The update brings the guidance into compliance with the goal of the Medical Device User Fee Amendments of 2017 to accelerate the review process, the agency said.

Full Story: